Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 22.06.2026 2 Am J Respir Crit Care Med 1 ASAIO J 1 Biomech Model Mechanobiol 1 BMC Cardiovasc Disord 1 BMJ Open Respir Res 1 Cardiovasc J Afr 2 Chest 1 Circ Heart Fail 1 Circ Res 1 Clin Chim Acta 1 Clin J Am Soc Nephrol 3 Clin Perinatol 1 Clin Rheumatol 1 Compr Physiol 1 Drug Discov Today 1 Eur Heart J Case Rep 2 Eur Respir J 1 Front Microbiomes 1 Front Pediatr 8 Heart Fail Clin 1 Heart Fail Rev 1 Heart Lung 1 Int J Biochem Cell Biol 1 Int J Cardiol Congenit Heart Dis 1 Int J Gen Med 1 J Bras Pneumol 2 J Cardiovasc Magn Reson 1 J Extra Corpor Technol 1 J Thorac Dis 2 J Thromb Haemost 1 JACC Case Rep 1 Kidney Med 1 Lupus Sci Med 1 Mol Biol Rep 1 Mol Cell Biochem 1 Proc Natl Acad Sci U S A 3 Pulm Circ 1 Respir Med Case Rep 1 Retina 1 Reumatol Clin (Engl Ed) 1 Ther Adv Respir Dis 1 Tuberc Respir Dis (Seoul) 1 Vascul Pharmacol 1 Vet Clin North Am Food Anim Pract

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. NIEDERER SA, Balmus M, Burr C, Chico TJA, et al
   Digital twins for cardiopulmonary medicine: the case for pulmonary arterial hypertension.
   Am J Respir Crit Care Med. 2026;212:1203-1213.
   PubMed         Abstract available
   
   
2. AGARWAL S, Bankar A, Heo L, Mitra A, et al
   CES1 deficiency is associated with metabolic reprograming and endothelial dysfunction in pulmonary arterial hypertension.
   Am J Respir Crit Care Med. 2026;212:1315-1329.
   PubMed         Abstract available
   
   

   
   ASAIO J

3. SMITH TM, Restaino K, Lipsitz S, Khurana JK, et al
   Extracorporeal Membrane Oxygenation in Pediatric Pulmonary Hypertension: A Single-Center Cohort to Inform Decision-Making.
   ASAIO J. 2026 Jun 22. doi: 10.1097/MAT.0000000000002766.
   PubMed         Abstract available
   
   

   
   Biomech Model Mechanobiol

4. MULLAGURA HN, Gharahi H, Figueroa CA, Baek S, et al
   Baseline state for pulmonary vasculature with pulmonary arterial hypertension: effect of geometric remodeling and metabolic shift.
   Biomech Model Mechanobiol. 2026;25:68.
   PubMed         Abstract available
   
   

   
   BMC Cardiovasc Disord

5. JIANG Y, Liu Z, Su C, Chen Y, et al
   Prevalence and risk factors of echocardiographically suspected pulmonary hypertension in maintenance hemodialysis patients: a retrospective study.
   BMC Cardiovasc Disord. 2026 Jun 15. doi: 10.1186/s12872-026-06128.
   PubMed         Abstract available
   
   

   
   BMJ Open Respir Res

6. TARRAS ES, Yan X, Gange C, Kurz S, et al
   Beyond PVR: dynamic physiologic assessment enhances prognostic evaluation in pulmonary hypertension associated with chronic obstructive pulmonary disease.
   BMJ Open Respir Res. 2026;13:e004192.
   PubMed         Abstract available
   
   

   
   Cardiovasc J Afr

7. HENEMA MM, Smit FE, Brown SC, Botes L, et al
   Clinical and echocardiographic characteristics of patients presenting with pulmonary hypertension due to congenital heart disease.
   Cardiovasc J Afr. 2026;37:53-61.
   PubMed         Abstract available
   
   

   
   Chest

8. MINHAS J, Shou H, Al-Naamani N, Feng R, et al
   Daily Physical Activity in Pulmonary Arterial Hypertension: Insights From a Multicenter Longitudinal Trial Using Accelerometry.
   Chest. 2026;169:1660-1671.
   PubMed         Abstract available
   
   
9. LU K, Barros LM, Murinova N, Buber J, et al
   Pulmonary Arterial Hypertension Associated With Calcitonin Gene-Related Peptide Antagonist Therapy for Migraine: A Case Series.
   Chest. 2026;169:e175-e179.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

10. REDDY YNV, Frantz RP, Egbe AC, Miranda WR, et al
    Phenotypic Characterization of Unclassified Pulmonary Hypertension.
    Circ Heart Fail. 2026 Jun 19:e014480. doi: 10.1161/CIRCHEARTFAILURE.125.014480.
    PubMed         Abstract available
    
    

    
    Circ Res

11. YANG S, Wang Z, Yang T, Liu Y, et al
    Restoring TRPV4-KCa2.3 Coupling to Treat Pulmonary Arterial Hypertension.
    Circ Res. 2026;139:e326135.
    PubMed         Abstract available
    
    

    
    Clin Chim Acta

12. VICENZI A, Pagnoni G, Coppi F
    Right ventricular-centered metabolomics: A promising tool for phenotyping pulmonary arterial hypertension.
    Clin Chim Acta. 2026;589:121025.
    PubMed         Abstract available
    
    

    
    Clin J Am Soc Nephrol

13. WING R, Erdbrupsilongger U, Miller E, Morsy M, et al
    Pulmonary Hypertension, the Forgotten Right Ventricle, and Vascular Access in Hemodialysis Patients.
    Clin J Am Soc Nephrol. 2026 Jun 12. doi: 10.2215/CJN.0000001147.
    PubMed        
    
    

    
    Clin Perinatol

14. WAMBACH JA, Cole FS, Nogee LM
    Evaluation and Management of Genetic Respiratory Disorders Presenting as Hypoxemic Respiratory Failure in the Newborn Infant.
    Clin Perinatol. 2026;53:381-401.
    PubMed         Abstract available
    
    
15. HUME P, Khanal L, Lakshminrusimha S, Sankaran D, et al
    Management of Hypoxemic Respiratory Failure in the Newborn During Therapeutic Hypothermia.
    Clin Perinatol. 2026;53:317-332.
    PubMed         Abstract available
    
    
16. YANG MJ, Douglass M, Carpenter RJ, Yoder BA, et al
    Respiratory Management for the Infant with Congenital Diaphragmatic Hernia.
    Clin Perinatol. 2026;53:277-295.
    PubMed         Abstract available
    
    

    
    Clin Rheumatol

17. ZHANG Y, Shan L, Dai J, Zhou Z, et al
    Prognostic value of cardiopulmonary exercise testing in connective tissue disease-associated pulmonary arterial hypertension at low and intermediate-low risk.
    Clin Rheumatol. 2026;45:3543-3553.
    PubMed         Abstract available
    
    

    
    Compr Physiol

18. KADOSH S, Baidats Y, Jones AM, Wilkerson D, et al
    Oxygen Supplementation Improves Oxygen Uptake Kinetics and Exercise Performance in PAH and CTEPH Patients.
    Compr Physiol. 2026;16:e70194.
    PubMed         Abstract available
    
    

    
    Drug Discov Today

19. TAN W, Hu Y, Hu L, Chen Z, et al
    Ferroptosis inhibitors: latest advances and therapeutic potential for pulmonary arterial hypertension.
    Drug Discov Today. 2026;31:104635.
    PubMed         Abstract available
    
    

    
    Eur Heart J Case Rep

20. LEBBINK JS, Smits M, van der Hoeven BL, Scholzel BE, et al
    Dynamic left main coronary artery compression by a dilated pulmonary artery in a patient with pulmonary hypertension-a case report demonstrating the significance of multimodular imaging.
    Eur Heart J Case Rep. 2026;10:ytag295.
    PubMed         Abstract available
    
    

    
    Eur Respir J

21. GRYNBLAT J, Coulet F, Gagnadoux F, Montani D, et al
    Reply: FLNA loss-of-function variants in pulmonary hypertension: implications for genetic testing in congenital heart disease.
    Eur Respir J. 2026;67:2600770.
    PubMed        
    
    
22. MORA-GOMEZ M, Cruz-Utrilla A, Miranda-Alcaraz L, Gallego-Zazo N, et al
    Comment on: Pulmonary hypertension in patients carrying FLNA loss-of-function variants.
    Eur Respir J. 2026;67:2600577.
    PubMed        
    
    

    
    Front Microbiomes

23. HAN Y, Zhang H, Zhang J
    Altered early-life gut microbiota in offspring of pregnancies complicated by CHD-associated pulmonary hypertension.
    Front Microbiomes. 2026;5:1785707.
    PubMed         Abstract available
    
    

    
    Front Pediatr

24. LI G, Du X, Luo W, Wei J, et al
    Efficacy and safety of bosentan-related therapy in neonates with persistent pulmonary hypertension of the newborn: a systematic review and meta-analysis.
    Front Pediatr. 2026;14:1836276.
    PubMed         Abstract available
    
    

    
    Heart Fail Clin

25. NARDI E, Abbellito GM, Marzano F, Gargiulo P, et al
    Pulmonary Hypertension: From Molecular Pathways to Patient Care.
    Heart Fail Clin. 2026;22:261-272.
    PubMed         Abstract available
    
    
26. MAVROMANOLI AC, Mavromanolis CA
    Advances in the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension.
    Heart Fail Clin. 2026;22:291-299.
    PubMed         Abstract available
    
    
27. MORAGON-LEDESMA S, Demelo-Rodriguez P, Galeano-Valle F
    Long-term Complications of Venous Thromboembolism: A Practical Guide.
    Heart Fail Clin. 2026;22:329-339.
    PubMed         Abstract available
    
    
28. NERINO S, Casella C, Capasso E, Marino F, et al
    Exercise Training and Cardiac Rehabilitation in Chronic Thromboembolic Pulmonary Hypertension.
    Heart Fail Clin. 2026;22:341-352.
    PubMed         Abstract available
    
    
29. JOHN T, Stauber RE, Douschan P
    Portopulmonary Hypertension: Current Perspectives.
    Heart Fail Clin. 2026;22:353-360.
    PubMed         Abstract available
    
    
30. BISCHOF E, Haber C, Lidstromer N
    The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension.
    Heart Fail Clin. 2026;22:361-370.
    PubMed         Abstract available
    
    
31. COHEN SP, Miller AL, Rajpal S, Visovatti SH, et al
    Recent Advances in Pulmonary Hypertension Management.
    Heart Fail Clin. 2026;22:371-385.
    PubMed         Abstract available
    
    
32. ABBAS KZ, Caton T, Rali P
    Long-term Complications of Pulmonary Embolism: Which Is the Optimal Follow-Up?
    Heart Fail Clin. 2026;22:387-397.
    PubMed         Abstract available
    
    

    
    Heart Fail Rev

33. CABADA-GARCIA MJ, Rodriguez-Rivera J, Panneflek J, Andrade-Leal S, et al
    Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.
    Heart Fail Rev. 2026;31:75.
    PubMed         Abstract available
    
    

    
    Heart Lung

34. HOCH CR, Brewer B, Matura LA
    Presenting symptom patterns of pulmonary arterial hypertension across adult age groups and etiologies: Implications for early recognition.
    Heart Lung. 2026;78:102837.
    PubMed         Abstract available
    
    

    
    Int J Biochem Cell Biol

35. ZHENG C, Huo Y, Zhang X, Wang F, et al
    xCT/SLC7A11-mTOR axis promotes vascular remodeling in pulmonary arterial hypertension.
    Int J Biochem Cell Biol. 2026;197-198:106969.
    PubMed         Abstract available
    
    

    
    Int J Cardiol Congenit Heart Dis

36. BALTODANO DANGLA CR, Romero Rios CK, Urbina Malianos CJ, Canales Reyes MA, et al
    Arterial tortuosity syndrome presenting as severe precapillary pulmonary hypertension in adulthood.
    Int J Cardiol Congenit Heart Dis. 2026;25:100683.
    PubMed         Abstract available
    
    

    
    Int J Gen Med

37. HAJIAHMADI S, Mirdamadi A, Tajmirriahi M, Fadavi S, et al
    Quantitative CT Pulmonary Angiography and Echo Cardiography Analysis for Enhanced Cardiovascular Assessment of Right Ventricular Failure in Pulmonary Hypertension.
    Int J Gen Med. 2026;19:612693.
    PubMed         Abstract available
    
    

    
    J Bras Pneumol

38. ALVES-JR JL, Amado VM, Correa RA, Campos FAFT, et al
    Diagnosis of pulmonary arterial hypertension: a statement from the Brazilian Thoracic Association.
    J Bras Pneumol. 2026;51:e20250065.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Magn Reson

39. WANG J, Guo J, Zhao J, He J, et al
    Characteristics and prognostic value of cardiovascular magnetic resonance imaging-derived left ventricular hemodynamics in pulmonary arterial hypertension.
    J Cardiovasc Magn Reson. 2026;28:102742.
    PubMed         Abstract available
    
    
40. VIRSINSKAITE R, Beattie CJ, Karia N, Kotecha T, et al
    Sotatercept improves right ventricular function but is associated with new or worsening pericardial effusions: a cardiovascular magnetic resonance study in intermediate-high risk pulmonary arterial hypertension.
    J Cardiovasc Magn Reson. 2026;28:102714.
    PubMed         Abstract available
    
    

    
    J Extra Corpor Technol

41. WIRTH C, De Normandie P, Hascoet S, Fadel E, et al
    Learning from a pitfall: Atrial septostomy in LV failure under VA-ECMO for pulmonary hypertension.
    J Extra Corpor Technol. 2026;58:180-183.
    PubMed         Abstract available
    
    

    
    J Thorac Dis

42. BAI Q, Liu H, Wang H, Yao Y, et al
    Clinical research on pulmonary hypertension from a 2025 perspective: a narrative review.
    J Thorac Dis. 2026;18:552.
    PubMed         Abstract available
    
    

    
    J Thromb Haemost

43. HOSOKAWA K, Kohei M, Hirose M, Inami T, et al
    Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry study.
    J Thromb Haemost. 2026 Jun 18:S1538-7836(26)00394.
    PubMed         Abstract available
    
    
44. FARMAKIS IT, Valerio L, Barco S, Hobohm L, et al
    Follow-up algorithm for detecting chronic sequelae of pulmonary embolism: diagnostic performance and possible limitations.
    J Thromb Haemost. 2026;24:2532-2543.
    PubMed         Abstract available
    
    

    
    JACC Case Rep

45. SAPKOTA S, Sharma P, Fadah K, Usle Perez EI, et al
    Off-Label 16-mm VSD Occluder for Closure of a Giant PDA With Severe Pulmonary Hypertension.
    JACC Case Rep. 2026 Jun 18:108891. doi: 10.1016/j.jaccas.2026.108891.
    PubMed         Abstract available
    
    

    
    Kidney Med

46. TUTTLE M, Tighiouart H, Oka T, McCallum W, et al
    The Association Between Pulmonary Hypertension, End-Stage Kidney Disease, and Death: An Analysis of the Chronic Renal Insufficiency Cohort Study (CRIC).
    Kidney Med. 2026;8:101399.
    PubMed         Abstract available
    
    

    
    Lupus Sci Med

47. WU Q, Zhou Z, Ye H, Zhang M, et al
    Belimumab as a possible treatment for SLE-associated pulmonary arterial hypertension: the experience from a single centre.
    Lupus Sci Med. 2026;13:e001960.
    PubMed         Abstract available
    
    

    
    Mol Biol Rep

48. WENG S, Ding C, Zhang H, Lai Y, et al
    The bile acid-oxysterol axis in pulmonary arterial hypertension: from sterol trafficking to precision phenotyping and therapeutic opportunities.
    Mol Biol Rep. 2026;53:964.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

49. TIAN H, Liu Z, He J, Wei R, et al
    Integrative multi-omics and machine learning reveal glycolysis-related biomarkers driving vascular remodeling in pulmonary arterial hypertension.
    Mol Cell Biochem. 2026;481:2639-2654.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

50. VILLARREAL ES, Marinho Y, Loya O, Aboagye SY, et al
    Endothelial c-IAP2 loss amplifies P2X7 receptor-driven inflammation and worsens schistosomiasis-associated pulmonary hypertension.
    Proc Natl Acad Sci U S A. 2026;123:e2513158123.
    PubMed         Abstract available
    
    

    
    Pulm Circ

51. 
    Correction to "Male Sex Is Associated With Severe Pulmonary Hypertension and Worse Outcome in Chronic Obstructive Pulmonary Disease Patients Referred for Right Heart Catheterization".
    Pulm Circ. 2026;16:e70338.
    PubMed         Abstract available
    
    
52. CHURCH C, Molina-Molina M, Arias-Guillen M, Muchmore P, et al
    A Phase 2 Study of the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Pulm Circ. 2026;16:e70322.
    PubMed         Abstract available
    
    
53. HARDCASTLE SJ, Wells Z, Keen C, Condliffe R, et al
    Factors Influencing Physical Activity Engagement Amongst Those Living With Pulmonary Hypertension in the UK.
    Pulm Circ. 2026;16:e70332.
    PubMed         Abstract available
    
    

    
    Respir Med Case Rep

54. VERA RICAURTE M, Kosak Lopez E, Geller A, Leguizamon R, et al
    Pulmonary vasodilator therapy in COPD-associated pulmonary hypertension: A real-world case series of 14 patients confirmed by right heart catheterization.
    Respir Med Case Rep. 2026;62:102443.
    PubMed         Abstract available
    
    

    
    Retina

55. LISHINSKY-FISCHER N, Levy J
    PROSTACYCLIN ANALOGS AND DIABETIC RETINOPATHY OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION : A Cohort Analysis.
    Retina. 2026;46:1251-1257.
    PubMed         Abstract available
    
    

    
    Reumatol Clin (Engl Ed)

56. CHACON-ABRIL K, Portela-Hernandez M, Fajardo-Hermosillo LD, Limon-Camacho L, et al
    Guide from the Colegio Mexicano de Reumatologia for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension.
    Reumatol Clin (Engl Ed). 2026;22:502164.
    PubMed         Abstract available
    
    

    
    Ther Adv Respir Dis

57. R MURAD M, Awashra A, S Elgendy M, Kasem AW, et al
    Clinical, hemodynamic, and safety outcomes of sotatercept in pulmonary arterial hypertension: a meta-analysis of randomized trials with time-to-event data.
    Ther Adv Respir Dis. 2026;20:17534666261459209.
    PubMed         Abstract available
    
    

    
    Tuberc Respir Dis (Seoul)

58. LES O, Aghabekyan T, Bhamidipati D, Belligund P, et al
    Use of anticoagulants as a supportive measure in pulmonary hypertension: a narrative review.
    Tuberc Respir Dis (Seoul). 2026 Jun 16. doi: 10.4046/trd.2026.0047.
    PubMed         Abstract available
    
    

    
    Vascul Pharmacol

59. LANGLEBEN D, Orfanos SE, Fox BD, Giovinazzo M, et al
    Decreased exercise-induced pulmonary capillary recruitment in pulmonary arterial hypertension.
    Vascul Pharmacol. 2026;163:107615.
    PubMed         Abstract available
    
    

    
    Vet Clin North Am Food Anim Pract

60. NEARY JM
    Review of Right Heart Failure.
    Vet Clin North Am Food Anim Pract. 2026;42:195-208.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum